Scientific Reports (Oct 2023)

Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry

  • José-Manuel Casas-Rojo,
  • Juan-Miguel Antón-Santos,
  • Jesús Millán-Núñez-Cortés,
  • Ricardo Gómez-Huelgas,
  • José-Manuel Ramos-Rincón,
  • Manuel Rubio-Rivas,
  • Miguel-Ángel Corrales-González,
  • Maria-Rosa Fernández-Madera-Martínez,
  • José-Luis Beato-Pérez,
  • Francisco Arnalich-Fernández,
  • Cristina Gállego-Lezaun,
  • Pablo Pérez-Martínez,
  • Sonia Molinos-Castro,
  • Yale Tung-Chen,
  • Manuel Madrazo,
  • Manuel Méndez-Bailón,
  • Daniel Monge-Monge,
  • Gema-María García-García,
  • Rosa García-Fenoll,
  • Noemí Gilabert,
  • Rebeca Fuerte-Martínez,
  • Marta Contreras-Sánchez,
  • Nicolás Rhyman,
  • Jorge Peris-García,
  • Carlos Lumbreras-Bermejo,
  • The SEMI-COVID-19 Network

DOI
https://doi.org/10.1038/s41598-023-42735-5
Journal volume & issue
Vol. 13, no. 1
pp. 1 – 18

Abstract

Read online

Abstract In 2020, the COVID-19 pandemic followed a two-wave pattern in most countries. Hospital admission for COVID-19 in one wave or another could have affected mortality, especially among the older persons. The objective of this study was to evaluate whether the admission of older patients during the different waves, before SARS-CoV-2 vaccination was available, was associated with a different mortality. We compared the mortality rates of patients hospitalized during 2020 before (first wave) and after (second wave) July 7, 2020, included in the SEMI-COVID-19 Registry, a large, multicenter, retrospective cohort of patients admitted to 126 Spanish hospitals for COVID-19. A multivariate logistic regression analysis was performed to control for changes in either the patient or disease profile. As of December 26, 2022, 22,494 patients had been included (17,784 from the first wave and 4710 from the second one). Overall mortality was 20.4% in the first wave and 17.2% in the second wave (risk difference (RD) − 3.2%; 95% confidence interval (95% CI) − 4.4 to − 2.0). Only patients aged 70 and older (10,973 patients: 8571 in the first wave and 2386 in the second wave) had a significant reduction in mortality (RD − 7.6%; 95% CI − 9.7 to − 5.5) (unadjusted relative risk reduction: 21.6%). After adjusting for age, comorbidities, variables related to the severity of the disease, and treatment received, admission during the second wave remained a protective factor. In Spain, patients aged 70 years and older admitted during the second wave of the COVID-19 pandemic had a significantly lower risk of mortality, except in severely dependent persons in need of corticosteroid treatment. This effect is independent of patient characteristics, disease severity, or treatment received. This suggests a protective effect of a better standard of care, greater clinical expertise, or a lesser degree of healthcare system overload.